세계의 비뇨기과 의료기기 시장 : 제품별, 용도별, 최종 사용자별, 지역별 - 예측(-2030년)

The global urology devices market is valued at an estimated USD 34.56 billion in 2025 and is projected to reach USD 46.26 billion by 2030, at a CAGR of 6.0% during the forecast period. The rising prevalence of chronic metabolic and cardiovascular diseases, including diabetes mellitus and hypertension, has significantly escalated the incidence of urological pathologies that necessitate prompt diagnostic assessment and surgical intervention.

Immediate and evidence-based clinical management is essential to prevent disease progression and optimize patient outcomes. Concurrently, the accelerating adoption of minimally invasive urological techniques, encompassing robotic-assisted procedures, endoscopic interventions, and percutaneous therapies, has substantially increased the demand for precision urology devices that ensure procedural safety, diagnostic accuracy, and therapeutic efficacy.

The consumables & accessories segment is projected to register the fastest growth rate in the urology devices market, by product category, during the forecast period.

The urology devices market is bifurcated into instruments and consumables & accessories based on product. The consumables & accessories segment is expected to expand at a higher compound annual growth rate. The high growth rate of the consumables & accessories segment is due to increased research and development initiatives focused on developing innovative solutions for managing the rising prevalence of chronic urological diseases. Additionally, the growing emphasis on reusable consumables, device standardization, and procedural efficiency has increased demand for consumables across hospitals, surgical centers, and outpatient facilities globally.

The dialysis centers segment is projected to register the highest growth rate in the urology devices market.

Based on end users, the urology devices market is segmented into hospitals, ASCs, clinics, dialysis centers, and home care settings. Dialysis centers are experiencing the highest growth rate. This accelerated growth can be attributed to the substantially increased demand for advanced dialysis equipment and specialized facilities required for managing end-stage renal disease (ESRD). The rising prevalence of chronic kidney disease globally, coupled with the escalating incidence of diabetes and hypertension driving renal failure cases, has created urgent demand for more dialysis centers and upgraded facility infrastructure. Additionally, technological advancements in dialysis technology, improved treatment protocols, and growing patient awareness are collectively driving investment in new dialysis facilities and modern equipment, thereby propelling the dialysis centers segment to emerge as the fastest-growing end-user category in the global urology devices market.

Asia Pacific is expected to be the fastest-growing region in the global urology devices market.

The Asia Pacific region is projected to register the highest CAGR during the forecast period. This accelerated regional growth is propelled by multiple interconnected factors, including the substantially rising geriatric population requiring advanced urological interventions, escalating prevalence of kidney disease, significant disease burden from chronic kidney disease (CKD) affecting millions across the region, rapidly increasing healthcare spending and per capita income levels, growing consumer demand for therapeutic technologies, strategic expansion of private-sector hospital networks into underserved rural areas across Asia Pacific countries, and the presence of emerging high-growth markets with untapped potential. Additionally, improvements in healthcare accessibility, government initiatives supporting the development of healthcare infrastructure, and rising patient awareness of advanced urological treatment options are collectively positioning the Asia Pacific region as the most dynamic and fastest-growing market for urology devices globally.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• * By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (20%)
• * By Designation: C Level (27%), Director Level (18%), and Others (55%)
• * By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and Middle East & Africa (4%)

List of Companies Profiled in the Report

• Fresenius Medical Care AG & Co. KGaA (Germany)
• Boston Scientific Corporation (US)
• Becton, Dickinson and Company (US)
• B. Braun Melsungen AG (Germany)
• Cardinal Health (US)
• Olympus Corporation (Japan)
• Intuitive Surgical (US)
• Coloplast A/S (Denmark)
• Stryker Corporation (US)
• Teleflex Incorporated (US)
• Convatec Group PLC (UK)
• Medtronic PLC (Ireland)
• Karl Storz (Germany)
• Cook Medical (US)
• Richard Wolf GmbH (Germany)
• CompactCath (US)
• Dornier MedTech (Germany)
• Well Lead Medical Co., Ltd. (China)
• ROCAMED (Germany)
• Amniso International, Inc. (US)
• Medispec (US)
• Vimex Sp. z o.o. (Poland)
• Balton Sp. z o.o. (Poland)
• Hunter Urology (UK)
• Ribbel International Ltd. (India)

Research Coverage

This research report categorizes the urology devices market by product (instruments and consumables & accessories), application (kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications), end user (hospitals, ASCS & clinics, dialysis centers and home care settings), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the growth of the urology devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions and services, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urology devices market. Competitive analysis of upcoming startups in the urology devices market ecosystem is covered in this report.

Key Benefits of Buying the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (Rising incidence of urological diseases, Growing preference for minimally invasive procedures, Technological advancements and increased R&D investments, Increasing number of hospitals and surgical centers) restraints (High degree of consolidation among key players), opportunities (Potential growth opportunities in emerging economies) and challenges (Increasing number of product recalls by key players, Shortage of urologists and trained professionals) influencing the growth of the urology devices market
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product launches in the urology devices market.
• Market Development: Comprehensive information about lucrative markets - the report analyzes the urology devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players, such as Fresenius Medical Care AG & Co. KGaA (Germany), Cardinal Health (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key secondary sources
    • 2.1.1.2 List of key secondary sources
    • 2.1.1.3 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key objectives of primary research
    • 2.1.2.2 List of primary sources
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Breakdown of primary interviews
    • 2.1.2.5 Insights from industry experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Revenue estimation of key players
    • 2.2.1.2 Annual reports and investor presentations
    • 2.2.1.3 Primary interviews
    • 2.2.1.4 Growth forecast
    • 2.2.1.5 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 PARAMETRIC ASSUMPTIONS
  • 2.4.2 GROWTH RATE ASSUMPTIONS
  • 2.4.3 SCOPE-RELATED ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN UROLOGY DEVICES MARKET
• 4.2 ASIA PACIFIC UROLOGY DEVICES MARKET, BY END USER AND COUNTRY
• 4.3 UROLOGY DEVICES MARKET, BY COUNTRY
• 4.4 UROLOGY DEVICES MARKET, BY REGION

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising incidence of urological diseases
    • 5.2.1.2 Growing preference for minimally invasive procedures
    • 5.2.1.3 Technological advancements and increased R&D investments
    • 5.2.1.4 Increasing number of hospitals and surgical centers
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High degree of consolidation among key players
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Potential growth opportunities in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Increasing number of product recalls by key players
    • 5.2.4.2 Shortage of urologists and trained professionals
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY TYPE
  • 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Antimicrobial-coated catheters
    • 5.9.1.2 Portable hemodialysis
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Smart catheters
    • 5.9.2.2 Connected health & remote sensors
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Wearable artificial kidney
• 5.10 PATENT ANALYSIS
• 5.11 TRADE ANALYSIS
  • 5.11.1 IMPORT DATA FOR HS CODE 841920
  • 5.11.2 EXPORT DATA FOR HS CODE 841920
• 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.13 REGULATORY ANALYSIS
  • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13.2 REGULATORY FRAMEWORK
    • 5.13.2.1 North America
      • 5.13.2.1.1 US
      • 5.13.2.1.2 Canada
    • 5.13.2.2 Europe
    • 5.13.2.3 Asia Pacific
      • 5.13.2.3.1 China
      • 5.13.2.3.2 Japan
      • 5.13.2.3.3 India
    • 5.13.2.4 Latin America
      • 5.13.2.4.1 Brazil
      • 5.13.2.4.2 Mexico
    • 5.13.2.5 Middle East
    • 5.13.2.6 Africa
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 BARGAINING POWER OF SUPPLIERS
  • 5.14.2 BARGAINING POWER OF BUYERS
  • 5.14.3 THREAT OF NEW ENTRANTS
  • 5.14.4 THREAT OF SUBSTITUTES
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.15.2 KEY BUYING CRITERIA
• 5.16 IMPACT OF AI/GEN AI ON UROLOGY DEVICES MARKET
  • 5.16.1 INTRODUCTION
  • 5.16.2 POTENTIAL OF AI
  • 5.16.3 IMPACT OF AI
  • 5.16.4 KEY COMPANIES IMPLEMENTING AI
  • 5.16.5 FUTURE OF AI
• 5.17 IMPACT OF 2025 US TARIFF ON UROLOGY DEVICES MARKET
  • 5.17.1 INTRODUCTION
  • 5.17.2 KEY TARIFF RATES
  • 5.17.3 PRICE IMPACT ANALYSIS
  • 5.17.4 IMPACT ON COUNTRY/REGION
    • 5.17.4.1 North America
    • 5.17.4.2 Europe
    • 5.17.4.3 Asia Pacific
  • 5.17.5 IMPACT ON END-USE INDUSTRIES
    • 5.17.5.1 Hospitals
    • 5.17.5.2 Clinics
    • 5.17.5.3 Ambulatory Surgical Centers (ASCs)
    • 5.17.5.4 Dialysis centers
    • 5.17.5.5 Home care settings

6 UROLOGY DEVICES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 INSTRUMENTS
  • 6.2.1 DIALYSIS DEVICES
    • 6.2.1.1 Hemodialysis devices
      • 6.2.1.1.1 Increasing use of dialysis machines to spur growth
    • 6.2.1.2 Peritoneal dialysis devices
      • 6.2.1.2.1 Rising technological advancements and increasing product approvals to propel market
  • 6.2.2 ENDOSCOPES
    • 6.2.2.1 Laparoscopes
      • 6.2.2.1.1 Lower surgical site infections to support growth
    • 6.2.2.2 Ureteroscopes
      • 6.2.2.2.1 Increased usage of ureteroscopy for kidney stones to drive market
    • 6.2.2.3 Nephroscopes
      • 6.2.2.3.1 High cost of maintenance to restrain market growth
    • 6.2.2.4 Resectoscopes
      • 6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to fuel market
    • 6.2.2.5 Cystoscopes
      • 6.2.2.5.1 Growing incidence of urological cancers to boost market
  • 6.2.3 LASER & LITHOTRIPSY DEVICES
    • 6.2.3.1 Associated benefits of lithotripsy devices to support growth
  • 6.2.4 ENDOVISION & IMAGING SYSTEMS
    • 6.2.4.1 Need for high-resolution images to aid growth
  • 6.2.5 ROBOTIC SYSTEMS
    • 6.2.5.1 Growing industry-academia collaborations to fuel market
  • 6.2.6 INSUFFLATORS
    • 6.2.6.1 Increasing volume of laparoscopic procedures to boost market
  • 6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS
    • 6.2.7.1 Growing incidence of chronic diseases to drive market
  • 6.2.8 URODYNAMIC SYSTEMS
    • 6.2.8.1 Rising patient pool to support growth
  • 6.2.9 OTHER INSTRUMENTS
• 6.3 CONSUMABLES & ACCESSORIES
  • 6.3.1 DIALYSIS CONSUMABLES
    • 6.3.1.1 Growing number of dialysis procedures to fuel market
  • 6.3.2 CATHETERS
    • 6.3.2.1 Intermittent catheters
      • 6.3.2.1.1 Rising clinical adoption of intermittent catheters to support growth
    • 6.3.2.2 Indwelling catheters
      • 6.3.2.2.1 Increased use in hospitals and home care settings to facilitate growth
    • 6.3.2.3 External catheters
      • 6.3.2.3.1 Growing preference for home-based management of chronic urinary conditions to drive market
  • 6.3.3 GUIDEWIRES
    • 6.3.3.1 Increasing number of surgeries and development of next-generation hybrid guidewires to drive market
  • 6.3.4 RETRIEVAL DEVICES & EXTRACTORS
    • 6.3.4.1 Growing number of kidney stone removal surgeries to fuel market
  • 6.3.5 SURGICAL DISSECTORS, FORCEPS & NEEDLE HOLDERS
    • 6.3.5.1 Rise in urology procedures to support growth
  • 6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS
    • 6.3.6.1 Increasing demand for effective endoscopic management of ureteral and renal calculi to aid growth
  • 6.3.7 STENTS & IMPLANTS
    • 6.3.7.1 Growing prevalence of urological, kidney-related disorders, and erectile dysfunction to propel market
  • 6.3.8 BIOPSY DEVICES
    • 6.3.8.1 High incidence of prostate cancer to contribute to growth
  • 6.3.9 TUBES & DISTAL ATTACHMENTS
    • 6.3.9.1 Increasing demand for endoscopy to boost market
  • 6.3.10 DRAINAGE BAGS
    • 6.3.10.1 Increasing prevalence of urinary incontinence and chronic kidney disease to foster growth
  • 6.3.11 OTHER CONSUMABLES & ACCESSORIES

7 UROLOGY DEVICE MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 KIDNEY DISEASES
  • 7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO DRIVE MARKET
• 7.3 UROLOGICAL CANCER
  • 7.3.1 RISING PREVALENCE OF UROLOGICAL CANCER TO CONTRIBUTE TO GROWTH
• 7.4 PELVIC ORGAN PROLAPSE
  • 7.4.1 HIGH COSTS INVOLVED IN SURGERIES & HIGH REOCCURRENCE RATES TO RESTRAIN GROWTH
• 7.5 BENIGN PROSTATIC HYPERPLASIA (BPH)
  • 7.5.1 INCREASING ELDERLY POPULATION TO AID GROWTH
• 7.6 URINARY INCONTINENCE (UI)
  • 7.6.1 NEED FOR PROPER DIAGNOSIS AND TREATMENT TO SUPPORT GROWTH
• 7.7 ERECTILE DYSFUNCTION
  • 7.7.1 INCREASING PREVALENCE OF PROSTATE CANCER TO AID GROWTH
• 7.8 URINARY STONES
  • 7.8.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO FUEL MARKET
• 7.9 OTHER APPLICATIONS

8 UROLOGY DEVICES MARKET - EPIDEMIOLOGY AND PREVALENCE ANALYSIS, 2023-2030 (NO. OF CASES/PREVALENCE)

9 UROLOGY DEVICES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 INCREASING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO EXPEDITE GROWTH
• 9.3 AMBULATORY SURGERY CENTERS
  • 9.3.1 LOWER COST AND SHORTER PATIENT STAYS TO PROMOTE GROWTH
• 9.4 CLINICS
  • 9.4.1 GROWING INTEGRATION OF ADVANCED TECHNOLOGY IN UROLOGY CLINICS TO PROPEL MARKET
• 9.5 DIALYSIS CENTERS
  • 9.5.1 RISING DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO AID GROWTH
• 9.6 HOME CARE SETTINGS
  • 9.6.1 LOWER COST AND SHORTER HOSPITAL STAYS TO BOOST MARKET

10 UROLOGY DEVICES MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Presence of large dialysis patient base and robust infrastructure to promote growth
  • 10.2.3 CANADA
    • 10.2.3.1 Increasing focus on preventing target diseases to expedite growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Presence of major urology device manufacturers to contribute to growth
  • 10.3.3 UK
    • 10.3.3.1 Rising incidence of kidney conditions to bolster growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Favorable government initiatives and shifting demographic trends to aid growth
  • 10.3.5 ITALY
    • 10.3.5.1 Increasing cases of chronic diseases to spur growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Rising geriatric population to accelerate growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK
  • 10.4.2 CHINA
    • 10.4.2.1 Rising incidence of target health conditions and decreasing mortality rate to facilitate growth
  • 10.4.3 JAPAN
    • 10.4.3.1 Large geriatric population and established healthcare system to support growth
  • 10.4.4 INDIA
    • 10.4.4.1 Large patient pool and rapidly growing healthcare sector to drive market
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK
  • 10.5.2 BRAZIL
    • 10.5.2.1 Rising cases of metabolic diseases to support growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Increasing prevalence of diabetes and kidney disorders to expedite growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
• 11.3 REVENUE ANALYSIS, 2022-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 COMPANY VALUATION AND FINANCIAL METRICS
• 11.6 BRAND/PRODUCT COMPARISON
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Product footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of key startups/SMEs
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Deals
      • 12.1.1.3.2 Expansions
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 BOSTON SCIENTIFIC CORPORATION
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches and approvals
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 B. BRAUN MELSUNGEN AG
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 BECTON, DICKINSON AND COMPANY
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 MnM view
      • 12.1.4.3.1 Key strengths
      • 12.1.4.3.2 Strategic choices
      • 12.1.4.3.3 Weaknesses and competitive threats
  • 12.1.5 OLYMPUS CORPORATION
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches and approvals
      • 12.1.5.3.2 Deals
      • 12.1.5.3.3 Expansions
  • 12.1.6 CARDINAL HEALTH
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Deals
  • 12.1.7 INTUITIVE SURGICAL
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches and approvals
  • 12.1.8 COLOPLAST A/S
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product launches and approvals
  • 12.1.9 STRYKER
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches and approvals
  • 12.1.10 TELEFLEX INCORPORATED
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches and approvals
  • 12.1.11 CONVATEC GROUP PLC
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
  • 12.1.12 MEDTRONIC PLC
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Expansions
• 12.2 OTHER PLAYERS
  • 12.2.1 KARL STORZ
  • 12.2.2 COOK MEDICAL
  • 12.2.3 RICHARD WOLF GMBH
  • 12.2.4 COMPACTCATH
  • 12.2.5 DORNIER MEDTECH
  • 12.2.6 NIKKISO CO., LTD.
  • 12.2.7 DIALIFE SA
  • 12.2.8 ERBE VISION
  • 12.2.9 WELL LEAD MEDICAL CO., LTD.
  • 12.2.10 ROCAMED
  • 12.2.11 ENDOMED SYSTEMS GMBH
  • 12.2.12 AMSINO INTERNATIONAL, INC.
  • 12.2.13 MEDISPEC
  • 12.2.14 VIMEX SP. Z O. O.
  • 12.2.15 BALTON SP. Z O.O.
  • 12.2.16 HUNTER UROLOGY
  • 12.2.17 RIBBEL INTERNATIONAL LIMITED

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS